Ella Watkins-Dulaney for Asimov PressBy Brian NaughtonOver the past few months, AI-based tools have emerged that enable scientists to design original antibodies on the computer for the first time. A year ago, none could reliably do this computationally. But now companies like Nabla Bio, Chai Discovery, Latent Labs, Manifold Bio and, most recently, DeepMind-spinoff Isomorphic Labs have allowed high success rates. There are even open source tools, such as BoltzGen and Germinal, that deliver simila...